A New Dosing Frontier: Retrospective Assessment of Effluent Flow Rates and Residual Renal Function Among Critically Ill Patients Receiving Continuous Renal Replacement Therapy

A New Dosing Frontier: Retrospective Assessment of Effluent Flow Rates and Residual Renal Function Among Critically Ill Patients Receiving Continuous Renal Replacement Therapy

OBJECTIVES:. In 2020, cefiderocol became the first Food and Drug Administration-approved medication with continuous renal replacement therapy (CRRT) dosing recommendations based on effluent flow rates (QE). We aimed to evaluate the magnitude and frequency of factors that may influence these recommen...

Full description

Bibliographic Details
Main Authors: Damini Lakshmipathy, Xiaoyi Ye, MD, Joseph L. Kuti, PharmD, FIDP, FCCP, David P. Nicolau, PharmD, FCCP, FIDSA, Tomefa E. Asempa, PharmD
Format: Article
Language:English
Published: Wolters Kluwer 2024-04-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000001065

Internet

http://journals.lww.com/10.1097/CCE.0000000000001065

Similar Items